Clinical Trials List
2024-06-11 - 2030-12-31
Phase III
Not yet recruiting2
Recruiting3
ICD-10C23
Malignant neoplasm of gallbladder
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9156.0
Malignant neoplasm of gallbladder
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- 林宗哲 無
- 莊建淮 無
- Ying-Chun Shen 無
- 黃信端 無
- 陳柏邑 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Ming-Lung Yu 無
- 張庭遠 無
- Chung-Feng Huang 無
- Wan-Long Chuang 無
- Chia-Yen Dai 無
- 梁博程 無
- Ming-Lun Yeh 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Shau-Hsuan Li 無
- 歐信佑 無
- 林昶廷 無
- 陳彥豪 無
- Yu-Li Su 無
- 吳佳哲 無
- 郭明濬 無
- 劉建廷 無
- Tai-Jan Chiu 無
- 黃詩喻 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Wen-Chi Chou 無
- Ming-Mo Hou 無
- 黃文冠 無
- Wen-Chi Shen 無
- Yung-Chia Kao 無
- 余紹銘 無
- Hung-Chih Hsu 無
- Po-Jung Su 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
10 participants
-
Global
286 participants
